Title: Clinical Observation of 63 Cases of Integrative Medicine in Treating Insulin Resistance of Diabetes Mellitus II
Abstract: Objective: To obverse the clinical efficacy and safety of Buzhong Yiqi decoction(补中益气汤,BZYQD) combined with Zhibai Dihuang pills(知柏地黄丸,ZBDHP) in treating insulin resistance of diabetes mellitus Ⅱ. Methods: 126 patients randomly divided into 2 groups, each 63 cases, which were given 7 points blood glucose monitoring. The control group was treated with Novolin 30R, while the treatment group was given Novolin 30 R, BZYQD and ZBDHP. The fasting blood-glucose, C-reactive protein, the dosage of insulin, the clinical efficacy and adverse reactions were observed. Results: After the treatment, the value of the fasting blood-glucose in treatment group is lower than the control group(P0.05). The difference of C-reactive protein between 2groups has no significance(P0.05). The dosage of insulin in treatment group is less than the control(P0.05). The total efficiency of the treatment group was 95.2%, and the control group was 79.4%, the former was significantly higher than the latter(P0.05). The total rate of adverse reactions was 7.9%, whlie the control group was 11.1%, the former was significantly lower than the latter(P0.05). Conclusion: BZYQD combined with ZBDHP can increase the clinical efficacy, decrease the dosage of insulin, and has a high security.
Publication Year: 2014
Publication Date: 2014-01-01
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot